In nude mice bearing PC‐3 human prostate cancer xenografts, DOX treatment significantly downregulated NEU1 expression while concomitantly increasing SIRT1 protein levels in tumor lysates (Figure S10d, Supporting Information). The gene discussed is SIRT1; the disease is prostate carcinoma.